We are deeply concerned for the people of Ukraine, including the VALOR-CKD clinical trial patients, investigators, site staff and our CRO colleagues who we have worked with for many years. Our thoughts and prayers are with the people of Ukraine. https://t.co/b8FrOfgy7O
A series of in vitro studies assessed drug-drug interactions of a potential treatment for #MetabolicAcidosis in #CKD. Learn more at the #KidneyWk poster. https://t.co/7nNuQ9mCDk
Learn more at #KidneyWk how patients with diabetes and #CKD are prone to functional limitations that adversely affect their quality of life. https://t.co/OITIcJgk9x
Is #MetabolicAcidosis associated with an increased risk of all-cause mortality in people with #CKD? A retrospective cohort study presented at #KidneyWk explored this question. Check out the poster to read about the findings!
Can age-related physical function be improved through the treatment of #MetabolicAcidosis in elderly #CKD patients? Learn more at our #KidneyWk presentation. https://t.co/QWRz8386eV
Does #MetabolicAcidosis increase the risk of progression to RRT? See the retrospective cohort study using data from electronic health records from over 51,000 people with non-dialysis #CKD in the US. #KidneyWk#CKDprogression
Tricida is a pharmaceutical company focused on treating #MetabolicAcidosis and slowing #CKDprogression. We look forward to sharing scientific findings to help navigate this disease. #KidneyWk
#MetabolicAcidosis is an independent risk factor for progression of #CKD, according to a retrospective cohort study presented at #KidneyWk. Check out the poster to learn about the findings! #CKDprogression
What is the relationship between serum bicarbonate & adverse #kidney outcomes in different races and ethnicities? See results using data from electronic medical records of people with #CKD in the United States in this #KidneyWk presentation. #CKDprogression
Can we do more to slow #CKD progression? Join us at #KidneyWk where our virtual experience explores the developments in slowing #ChronicKidneyDisease progression and what still remains to be addressed.
What is the correlation between subjective and objective measurements of daily activities in people with #MetabolicAcidosis and non-dialysis #CKD? Data is being presented at #KidneyWk. https://t.co/US8QBdFdDY
What are the effects of blood pressure, weight or volume overload in people with #MetabolicAcidosis and #CKD, including those with CHF? Data is being presented at #KidneyWk. https://t.co/F9LUJg24OM